The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?

Overview of attention for article published in Frontiers in Pharmacology, April 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 7,422 followers.

The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can… https://t.co/2UsX64CMmU #breastcancer

RT @DrTracyO: Our latest paper. A review of the role of CYP19A1 variation in aromatise inhibitor outcome. https://t.co/rD7pmF4on4

Our latest paper. A review of the role of CYP19A1 variation in aromatise inhibitor outcome. https://t.co/rD7pmF4on4

The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1… https://t.co/KtZX6hKnk8

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.